Detail publikačního výsledku

Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.

PEKAŘÍK, V.; GUMULEC, J.; MASAŘÍK, M.; KIZEK, R.; ADAM, V.

Original Title

Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.

English Title

Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.

Type

WoS Article

Original Abstract

More surprising are the findings that levels of various miRNAs are well correlated with presence of specific tumours and formation of metastases. Moreover, these small regulatory molecules play a role in the resistance of cancer cells to commonly used anti-cancer drugs, such as cisplatin, anthracyclines, and taxanes. In that respect, miRNAs become very attractive target for potential therapeutic interventions

English abstract

More surprising are the findings that levels of various miRNAs are well correlated with presence of specific tumours and formation of metastases. Moreover, these small regulatory molecules play a role in the resistance of cancer cells to commonly used anti-cancer drugs, such as cisplatin, anthracyclines, and taxanes. In that respect, miRNAs become very attractive target for potential therapeutic interventions

Keywords

Prostate carcinoma, markers, miRNA, circulating miRNAs, metallothionein, anti-cancer drugs, platinum based cytostatics, zinc, resistance, metastases.

Key words in English

Prostate carcinoma, markers, miRNA, circulating miRNAs, metallothionein, anti-cancer drugs, platinum based cytostatics, zinc, resistance, metastases.

Authors

PEKAŘÍK, V.; GUMULEC, J.; MASAŘÍK, M.; KIZEK, R.; ADAM, V.

RIV year

2014

Released

01.01.2013

ISBN

0929-8673

Periodical

CURRENT MEDICINAL CHEMISTRY

Volume

20

Number

4

State

United Arab Emirates

Pages from

534

Pages to

544

Pages count

11

Full text in the Digital Library

http://hdl.handle.net/

BibTex

@article{BUT98895,
  author="Vladimír {Pekařík} and Jaromír {Gumulec} and Michal {Masařík} and René {Kizek} and Vojtěch {Adam}",
  title="Prostate cancer, miRNAs, metallothioneins and resistance to cytostatic drugs.",
  journal="CURRENT MEDICINAL CHEMISTRY",
  year="2013",
  volume="20",
  number="4",
  pages="534--544",
  issn="0929-8673"
}